drugset / Trial / NCT06854445
Clinical Trial of TQB2825 Injection Combined With Chemotherapy in Subjects With Diffuse Large B-cell Lymphoma
Phase 2
Recruiting
55 enrolled
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the preliminary efficacy of TQB2825 in combination with chemotherapy in subjects with diffuse large B-cell lymphoma.
Timeline
- Start
- 2025-03-12
- Primary completion
- 2025-10
- Completion
- 2028-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TQB2825 | Unknown | — | — |
| Background | Gemcitabine | Small molecule | — | — |
| Background | Oxaliplatin | Small molecule | — | — |